Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07638215Recruiting
Open-label, single-arm trial in Corneal stromal defect. Primary endpoint: Incidence of Ocular Adverse Events and Hydrogel-Related Ocular Complications at 2 months. Started Sep 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07638215.